N-acetyl-seryl-aspartyl-lysyl-proline: A valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes

• 主要な著者: Keizo eKanasaki (著者), Takako eNagai (著者), Kyoko eNitta (著者), Munehiro eKitada (著者), Daisuke eKoya (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2014-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Fibroproliferative diseases are responsible for 45% of deaths in the developed world. Curing organ fibrosis is essential for fibroproliferative diseases. Diabetic nephropathy is a common fibroproliferative disease of the kidney and is associated with multiorgan dysfunction. However, therapy to comba...